Specialists in the fields of allergology, pulmonology, pediatric pulmonology and family medicine have prepared a joint position on the transition of medical aerosols in light of EU environmental regulations.

Experts fully support the efforts of the European Union to protect the environment and improve the quality of life of citizens, but express strong opposition to the potential threat to the availability or complete prevention of access to essential medicines for patients suffering from respiratory diseases who require the use of inhaled medicines, e.g. in the case of asthma or chronic obstructive pulmonary disease (COPD).

The submitted position presents a joint proposal of experts to introduce changes to the proposed regulations.

Full text of the position: https://bit.ly/3Ncdh6J


 

Latest news

Woman of the “Health Market” 2026

During yesterday's Gala of the 11th Health Challenges Congress, the "Women of the Health Market" ranking was announced. This distinction is awarded to female managers,

World Asthma Day 2026

Asthma affects over 260 million people worldwide and causes over 450,000 deaths annually, most of which are preventable with proper treatment. The greatest barrier remains

Cooperation with WHIH

The Coalition for Asthma Treatment is an active partner of the Warsaw Health Innovation Hub – a joint project of the Medical Research Agency and